Published in

Elsevier, Journal of the American College of Cardiology, 24(56), p. 2051-2066, 2010

DOI: 10.1016/j.jacc.2010.09.010

Lippincott, Williams & Wilkins, The American Journal of Gastroenterology, 12(105), p. 2533-2549, 2010

DOI: 10.1038/ajg.2010.445

Elsevier, Year Book of Gastroenterology, (2011), p. 15-17

DOI: 10.1016/j.ygas.2011.07.124

Links

Tools

Export citation

Search in Google Scholar

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Journal article published in 2010 by Neena S. Abraham, Mark A. Hlatky ORCID, Elliott M. Antman, Deepak L. Bhatt, David J. Bjorkman, Craig B. Clark, Curt D. Furberg, David A. Johnson, Charles J. Kahi, Loren Laine, Kenneth W. Mahaffey, Eamonn M. Quigley, James Scheiman, Laurence S. Sperling, Gordon F. Tomaselli and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

ACS=acute coronary syndromes; ADP=adenosine diphosphate; CI=confidence interval; CV=cardiovascular; GI=gastrointestinal; HR=hazard ratio; H2RA=histamine H2 receptor antagonist; MI=myocardial infarction; NNH=number-needed-to-harm; NSAID=nonsteroidal anti-inflammatory drug; OR=odds ratio; PCI=percutaneous coronary intervention; PPI=proton pump inhibitor; RCT=randomized clinical trial; RR=relative risk; VASP=vasodilator-stimulated phosphoprotein